Background /Aims: Accumulating evidence indicates that endothelial inflammation is one of the critical determinants in pathogenesis of atherosclerotic cardiovascular disease. Our previous studies had demonstrated that Vaccariae prevented high glucose or oxidative stresstriggered endothelial dysfunction in vitro. Very little is known about the potential effects of hypaphorine from Vaccariae seed on inflammatory response in endothelial cells. Methods:
Introduction
Endothelial cells are critical components of blood vessel that play vital roles in the regulation of vascular homeostasis [1, 2] . The functional destruction in endothelial cells contributes to the development and progression of vascular disease [3] . The endothelial dysfunction has been identified to be a high risk factor for cardiovascular diseases [4] . The inflammatory response produces numerous inflammatory mediators to accelerate the apoptosis of endothelial cells, and vascular permeability [5] . The endothelial cell activation in response to inflammatory stimuli is an initial event in diabetic retinopathy [6] and atherosclerosis [7] .
Endothelial dysfunction can be modulated by various stress signals in which inflammation plays an essential role [8] . On the other hand, endothelial dysfunction is fundamentally responsible for prothrombotic and proinflammatory state of the vasculature [9, 10] . Inflammation disrupts normal functionality of the endothelial cells, contributing to the development and progression of cardiometabolic diseases [11] . Prevention of excessive endothelial inflammation may provide promising approaches for treatment of inflammationrelated cardiovascular diseases [12] .
Complementary and alternative medicine has attracted tremendous attention due to their anti-inflammatory and antioxidative properties [13, 14] . Various herbs are currently employed to treat inflammatory disorders [15] . The increasing documents have suggested that complementary and alternative therapeutic strategies are widely used to ameliorate inflammatory state in cardiovascular disorders including atherosclerosis [13, 16] . Vaccarin is one of the major flavonoid glycoside in Vaccariae seed, which is believed to treat vascular diseases. Our previous studies have revealed that hydrogen peroxide-induced decrease in endothelial cell viability was selectively restored by vaccarin treatment [17] . Vaccarin is able to protect the vascular endothelial cells from injury triggered by high glucose [18] . Reconstruction of bacterial cellulose-vaccarin promotes wound healing in mice [19] . Hypaphorine from different marine sources is shown to possess anti-inflammatory properties [20] . Hypaphorine was a key monomer of Vaccaria segetalis. However, whether and how vaccariae hypaphorine (VH) is involved in endothelial inflammation, remains largely unknown. In this study, we demonstrated for the first time that VH attenuated LPS-mediated endothelial inflammation via regulation of toll-like receptor 4 (TLR4) and peroxisome proliferator-activated receptor γ (PPARγ), dependent on adenosine monophosphateactivated protein kinase (AMPK) activation.
Materials and Methods

Reagents and chemicals
Vaccaria hypaphorine (VH, Fig. 1 ) was purchased from Shanghai Shifeng technology Co., Ltd., China. Human endothelial EA·hy926 cells were obtained from American Type Culture Collection (Rockville, MD, USA). RNAiso Plus reagent was purchased from Takara Co. (Takara, Otsu, Shiga, Japan). Lipopolysaccharide (LPS), pioglitazone, 5-Aminoimidazole-4-carboxamide riboside or acadesine (AICAR) were purchased from Sigma Chemical Co. (St Louis, MO, USA). AMPK inhibitor compound C was obtained from Selleckchem Chemicals (Houston, TX, USA). AMPK activator A769662 was purchased from Tocris Biosciences (Ellisville, MO, USA). Antibodies against GAPDH and goat anti-rabbit IgG H&L (Alexa Fluor® 488) were purchased from Abcam (Cambridge, MA, USA). Antibodies against total or phosphorylated AMPK, total or phosphorylated acetyl-CoA carboxylase (ACC) were obtained from Cell Signaling Technology (Beverly, MA, USA). Antibodies against toll-like receptor 4 (TLR4), peroxisome proliferator-activated receptor γ (PPARγ) and HRP-labeled goat anti-rabbit secondary antibody was purchased from Wuhan Sanying Biotechnology Co. Ltd. (Chinese branch). The specific primers, siRNA sequences targeted TLR4 and negative siRNA sequences were synthesized by SangonBiotech Co.,Ltd. (Shanghai, China).The concentration of inhibitors or agonist used in the present study was determined according to previous studies and our preliminary studies. Cell culture Human EA·hy926 endothelial cells were cultured in DMEM medium supplemented with 10% bovine serum and incubated at 37 °C in a humidified air containing 5% CO 2 . The growth medium was replaced every 1-2 day and the cells were seeded onto petridishes or multiwell plates at a ratio of 1 to 3 upon 80% confluency.
Real-time quantitative PCR analysis
Total RNA was collected using Trizol reagent. Equal RNA levels (0.5 μg) from each sample were reversed transcribed into cDNA using HiScriptQ RT SuperMix for qPCR (Vazyme, Nanjing, China). The real-time quantitative PCR was conducted using ChamQTM SYBR® qPCR Master Mix (Vazyme, Nanjing, China).The mRNA levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), vascular cellular adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein 1 (MCP-1) were detected by a fluorescence quantitative LightCycler 480 Real Time PCR system (Roche, Basel, Sweden). The relative quantification of gene expression was calculated by using the 2 −ΔΔCt method. The sequences of primers were listed in the table Table 1 .
Western blotting analysis
The stimulated cells were lysed and the protein concentration of the cell lysates was measured using BCA Protein Assay Kit (Beyotime, Nanjing, China). Equal amount of proteins lysates were separated onto sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and electro-transferred onto nitrocellulose membrane (Millipore, Darmstadt, Germany). The blots were then subsequently incubated with the corresponding secondary antibodies conjugated to horseradish peroxidase. The positive bands were visualized by enhanced chemiluminescence (Millipore Darmstadt, Germany). Data were normalized to GAPDH.
Immunofluorescence staining
After treatment, the cells were fixed with 4% formaldehyde for 30 min, and then permeabilized with 0.1% Triton X-100 in PBS for 15 min. After incubation with 10% goat serum for 30 min, and incubated with indicated primary antibody rabbit anti-TLR4 or PPAR-γ overnight at 4°C. The cells were then incubated with goat anti-rabbit IgG H&L Alexa Fluor® 488 for 30 minutes. Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) after immunofluorescence staining. Immunofluorescence signals were visualized on a fluorescence microscope (80i, Nikon, Japan).
siRNA transfections
Human endothelial EA·hy926 cells were seeded onto six wells an initial density of 10 5 cells/ ml to form a monolayer on the day before the transfection. Cells at 30-40% confluent were washed and suspended in fresh medium without antibiotics and transfected separately with siRNA-TLR4 (100 nM), scramble (control) siRNA (100 nM) by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocols. After 6 hours of incubation, the medium was changed by fresh medium supplemented with 10% serum and antibiotics. Cells were incubated with LPS for an additional 48 hours. The siRNA sequences targeted TLR4 were as follows: sense, 5'-GGGCUUAGAACAACUAGAATT-3'; antisense, 5'-UUCUAGUUGUUCUAAGCCCTT-3'. The control siRNA sequences were as follows: sense, 5'-UUCUCCGAACGUGUCACGUTT-3'; antisense, 5'-ACGUGACACGUUCGGAGAATT-3'. The siRNA targeted TLR4 has been demonstrated to exhibit the most efficient silencing of TLR4 as previous report [21] . 
Results
Effects of VH on the inflammatory response in LPS-treated EA.hy926 cells
Endothelial inflammation is initiated and deteriorated by overproduction of inflammatory mediators [22, 23] . LPS is recognized as a danger signal that induces endothelial dysfunction [24, 25] . To examine whether VH exerted anti-inflammatory actions in human endothelial cells, the endothelial EA.hy926 cells were incubated with different concentrations of VH. Treatment of endothelial EA.hy926 cells with LPS time-dependently upregulated the mRNA levels of TNF-α, IL-1β, VCAM-1 and MCP-1 ( Fig. 2A) . Different doses of VH had no significant effect on TNF-α, IL-1β, VCAM-1 and MCP-1 mRNA expressions in endothelial cells (Fig. 2B) . However, the increased TNF-α, IL-1β, VCAM-1 and MCP-1 levels in endothelial cells response to LPS were obviously prevented by VH in a dose-related manner (Fig. 2C) . Interestingly, only middle or high dose of VH was able to inhibit the expressions of TNF-α, IL-1β, VCAM-1 and MCP-1 in LPS-challenged endothelial cells, thus the high dose of VH (200 μM) was selected for the next research in vitro.
TLR4 inhibition was involved in the anti-inflammatory roles of VH
Toll-like receptors complex (TLRs) signalling pathways, particularly TLR4, are activated by LPS, which induces excessive expressions of inflammatory cytokines [26] . We next determined whether TLR4 was involved in the anti-inflammatory roles of VH on EA.hy926 cells. Incubation of endothelial EA.hy926 cells with LPS obviously triggered the protein 
expressions of TLR4 in a time-dependent fashion ( Fig. 3A and 3D) , VH, by itself, had no direct effect on TLR4 protein expressions ( Fig. 3B and 3E) . Nevertheless, pretreatment with VH significantly abolished LPS-mediated up-regulation of TLR4 ( Fig. 3C and 3F ). In addition, immunofluorescence assay further demonstrated that VH could restrain the immunoreactivity of TLR4 in LPS-stimulated endothelial EA.hy926 cells (Fig. 3G) . Importantly, knockdown of TLR4 by siRNA inhibited the expressions of TNF-α, IL-1β, VCAM-1 and MCP-1 in EA.hy926 cells in response to LPS (Fig. 3H) .
Activation of PPARγ mediated the protective effects of VH
PPARγ is a nuclear receptor of ligand-activated transcriptional factors, and plays protective roles against endothelial inflammation in atherosclerosis [27, 28] . To further explore the possibility that VH may increase endothelium-derived PPARγ to retard LPSinduced inflammation response, we measured the PPARγ protein expressions in VHincubated endothelial cells. The protein levels of PPARγ were significantly reduced in the EA.hy926 cells upon exposure to LPS (Fig. 4A and 4D) , VH had no effect on protein levels ( Fig. 4B and 4E) . However, the down-regulation of PPARγ response to LPS was obviously its downstream effector ACC (Fig. 6A and 6B) , VH had no effect on the phosphorylation levels of AMPK and ACC (Fig. 6C and 6D) . However, VH treatment significantly resisted LPS-induced decreases in phosphorylation of AMPK and ACC (Fig. 6E) . Besides, both AMPK agonist AICAR (Fig. 7A ) and AMPK activator A769662 (Fig. 7B ) significantly impeded the LPS induced overproduction of pro-inflammatory cytokines.
AMPK signalling was responsible for the crosstalk between PPARγ and TLR4
It has been reported that metformin plays a cardioprotective role in LPS-induced sepsis via AMPK-mediated suppression of TLR4 activity [36] . Thymol promotes the expressions of brown fat-specific markers including PPARγ via activation of AMPK signalling [37] . Pretreatment with AMPK agonist AICAR significantly prevented the increased TLR4 protein expressions ( Fig. 8A and 8B ), but rescued the decreased PPARγ protein levels ( Fig. 8C and 8D ) in LPS-incubated EA.hy926 cells. Pretreatment with AMPK activator A769662 reversed LPSmediated modulations of TLR4 (Fig. 8E and 8F) and PPARγ ( Fig. 8G and 8H) . Furthermore, blockade of AMPK with Compound C abolished the effects of VH on inhibition of TLR4 ( Fig.  9A and 9B ) or activation of PPARγ (Fig. 9C and 9D ) in endothelial cells in response to LPS. More important, inhibition of AMPK with Compound C abolished the anti-inflammatory effect of VH on endothelial cells in response to LPS (Fig. 9E) .
Discussion
Endothelial cells are described to maintain homeostasis via modulation of vascular permeability, coagulation, angiogenesis and blood pressure [3] . The endothelium injury leads to recruitment of circulating inflammatory cells into the vessel wall to perpetuate vascular diseases such as atherosclerosis [38] . A better understanding of inflammationinduced endothelial dysfunction may be helpful for developing new therapeutic strategies for Endothelial dysfunction is a prominent feature of cardiovascular diseases and a harbinger of various cardiovascular events [39] . The proinflammatory cytokines are capable of driving endothelial dysfunction, contributing to the progression of cardiovascular events [40] . In this study, our results showed that the increased inflammation cytokines including TNF-α, IL-1β, VCAM-1 and MCP-1 response to LPS were abolished by pretreatment with VH. These results hinted that VH played a protective role against LPS-inflammation in endothelial EA.hy926 cells.
TLRs belong to a family of highly conserved pathogen recognition receptors, and are key regulators of innate immunity [41] . Endothelial cells have been indicated to express pattern-recognition receptors such as TLR4 with respect to pathogens, damage signals and inflammatory stimulant [3] . It has been established that endothelial cell-derived TLR4, rather than TLR4 from platelets and leukocytes, exerts a pivotal role in the formation of thrombus [42] . In the present study, our data exhibited that the protein levels of TLR4 were increased in endothelial cells exposed to LPS, but VH inhibited the upregulated TLR4 expressions response to LPS. In addition, knockdown of TLR4 by siRNA inhibited the expressions of TNF-α, IL-1β, VCAM-1 and MCP-1 in LPS-incubated EA.hy926 cells. These results indicated that VH may attenuate LPS-stimulated endothelial inflammation through inhibition of TLR4.
PPARγ is one of the nuclear receptors of ligand-activated transcriptional factors, and PPARγ activation impedes inflammation response in endothelial cells [28] . It is reported that cimiside E, 23-O-actylshengmanol-3-xyloside, isoimperatorin isolated from Cimicifugae Rhizome exhibits anti-inflammatory actions at least by upregulation of PPARγ [43] . In this study, we showed that LPS inhibited the protein levels of PPARγ, and VH eliminated LPSinduced suppression of PPARγ expression. Moreover, PPARγ agonist pioglitazone prevented LPS-induced up-regulations of inflammatory cytokines in EA.hy926 cells. These results indicated that VH could block LPS-induced inflammatory cytokines via activating PPARγ in endothelial cells. It is noted that gene silencing of TLR4 reversed the downregulated PPARγ levels in EA.hy926 cells response to LPS, and PPARγ agonist pioglitazone treatment abolished LPS-mediated upregulated TLR4 expressions. These results unveiled that both PPARγ activation and TLR4 suppression may coordinately participate in the protective effects of VH on inflammation cascade in endothelial cells induced by LPS.
AMPK, as an energy sensor, is ubiquitously expressed in vascular cells, and exerts antiatherosclerotic effects associated to suppression of inflammatory responses [44] [45] [46] . The beneficial effects of adiponectin on cardiovascular diseases are expected to be partially mediated by activation of AMPK signalling pathway [47] . The DPP-4 inhibitor sitagliptin significantly decreases the expressions of MCP-1 and IL-6 in the aorta of apolipoprotein-E-knockout mice via induction of AMPK phosphorylation [48] . C1q/TNF-related protein 9 stimulates the phosphorylation of AMPK and its downstream effector ACC, thus contributing to block cytokine-induced vascular inflammation and leukocyte adhesiveness in human aortic endothelial cells [34] . Our results showed that LPS-stimulated EA.hy926 cells had a lower phosphorylated AMPK and ACC, which was abolished by VH. Activation of AMPK by AICAR or A769662 diminished the excessive expressions of inflammatory cytokines and adhesion molecules in EA.hy926 cells induced by LPS. Moreover, the negative interactions between TLR4 and PPARγ triggered by LPS were modulated by AMPK signalling pathway. These results demonstrated that AMPK-dependent negative feedback loop of TLR4 and PPARγ was critically involved in protective roles of VH in LPS-stimulated endothelial inflammation. It is particularly worth noting that VH itself had no direct effect on TLR4, PPARγ or especially on AMPK activation, but it inhibited LPS-induced changes in these. We speculated that VH exerted functional modulations of TLR4, PPARγ or AMPK activation in LPS-incubated EA.hy926 cells, but not involved in regulating basal TLR4, PPARγ or AMPK under normal physiological condition.
